BioPharma Credit (LON:BPCR) Shares Up 0.7% – Still a Buy?

by · The Cerbat Gem

BioPharma Credit (LON:BPCR – Get Free Report)’s share price shot up 0.7% on Tuesday . The stock traded as high as GBX 0.88 ($0.01) and last traded at GBX 0.88 ($0.01). 167,973 shares traded hands during mid-day trading, a decline of 89% from the average session volume of 1,572,211 shares. The stock had previously closed at GBX 0.87 ($0.01).

BioPharma Credit Price Performance

The firm has a market cap of £10.51 million, a price-to-earnings ratio of 10.95 and a beta of 0.22. The company’s 50 day simple moving average is GBX 0.88 and its 200 day simple moving average is GBX 0.88.

BioPharma Credit Increases Dividend

The firm also recently declared a dividend, which was paid on Tuesday, October 29th. Shareholders of record on Thursday, September 26th were issued a $0.04 dividend. This represents a dividend yield of 4.26%. The ex-dividend date was Thursday, September 26th. This is an increase from BioPharma Credit’s previous dividend of $0.02. BioPharma Credit’s dividend payout ratio is 8,750.00%.

BioPharma Credit Company Profile

(Get Free Report)

BioPharma Credit PLC, an investment trust, primarily invests in interest-bearing debt assets. Its debt assets are secured by royalties or other cash flows derived from the sales of approved life sciences products. The company was incorporated in 2016 and is based in London, the United Kingdom.

See Also